Radiopharm Theranostics (ASX:RAD, Nasdaq: RADX, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that members of management will be participating in the D. Boral Capital Inaugural Global Conference on May 14, 2025, in New York…
(TheNewswire) NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER,…
Cardiex Limited (CDX:AU) has announced Lodgement of CONNEQT Pulse Device with the TGA Download the PDF here. This post…
Warren Buffett has a formidable reputation as an investor — with a net worth of US$160 billion in May…
The energy revolution is here to stay, and electric vehicles (EVs) have become part of the mainstream narrative. The…
General Motors’ (GM) (NYSE:GM) decision to cut a third shift at its Oshawa, Ontario, assembly plant this fall has…
AngloGold Ashanti (NYSE:AU,JSE:ANG)has agreed to sell its interests in two Côte d’Ivoire gold projects to Resolute Mining (ASX:RSG,LSE:RSG) as…
Riverside Resources Inc. (TSXV: RRI) (OTCQB: RVSDF) (FSE: 5YY) (‘Riverside’ or the ‘Company’), is pleased to announce that further…
